CLU and early-onset autosomal dominant Alzheimer disease: The result was consistent with previous studies showing multiple bands in a study when clusterin was first cloned, in human blood and cerebrospinal fluid (CSF) of patients with Alzheimer’s disease, and in colon cancer cells in vitro [68–70].